SDGR Schrödinger, Inc.
$28.90 -11.35%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-11.35%
YTD
+43.40%
P/E
—
P/B
3.62
ROE
-16.4%
Div yield
—
Beta
1.62
Market cap
$2.3B
RSI (14)
58
Next earnings
Nov 3, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$32.78
Close
$28.90
VWAP (n/a)
—
Day high
$33.78
Day low
$28.56
Volume
5.3M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Schrodinger Stock Has Technical Strength as It Hits New 2-Year Highs
Yahoo Finance · Sep 23
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance · Sep 17
Schrodinger (SDGR) Soars 12.1%: Is Further Upside Left in the Stock?
Yahoo Finance · Sep 16
Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs
Yahoo Finance · Sep 9
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
Yahoo Finance · Sep 1
Schrodinger Q2 Earnings Call Highlights
Yahoo Finance · Aug 6
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Aug 5, 2026 View → 8-K Aug 5, 2026 View → 8-K Jun 29, 2026 View → 8-K Jun 23, 2026 View → 8-K Jun 8, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell SDGR. Try it in the Lab to size a position and see the risk.